РЕЗУЛЬТАТЫ ПРИМЕНЕНИЯ БЕССТЕПЛЕРНОГО МИНИ-ГАСТРОШУНТИРОВАНИЯ В ЛЕЧЕНИИ МЕТАБОЛИЧЕСКОГО СИНДРОМА: РАНДОМИЗИРОВАННОЕ КЛИНИЧЕСКОЕ ИССЛЕДОВАНИЕ
https://doi.org/10.17238/issn2223-2427.2019.2.5-10
摘要
В представленной статье впервые описывается оценка эффективности разработанного бесстеплерного метода мини-гастрошунтирования по сравнению со стандартным степлерным методом для лечения метаболического синдрома. В результате применения установлено, что авторская и стандартная методики гастрошунтирования в одинаковой степени положительно влияют на устранение основных проявлений метаболического синдрома.
关于作者
О. Оспанов
Медицинский университет «Астана»; Корпоративный фонд “University Medical Center”
哈萨克斯坦
哈萨克斯坦
Г. Елеуов
Корпоративный фонд “University Medical Center”
哈萨克斯坦
哈萨克斯坦
Ф. Бекмурзинова
Корпоративный фонд “University Medical Center”
哈萨克斯坦
哈萨克斯坦
参考
1. Benraouane F., Litwin S.E. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol, 2011, 26(6), pp. 555–561. doi:10.1097/HCO.0b013e32834b7fc4
2. Sjöström L., Narbro K., Sjöström C. The Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med, 2007, 357, pp. 741-752.
3. Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol, 2014, 20(41), pp. 15135–15143. doi:10.3748/wjg.v20.i41.15135
4. Ospanov O.B. OBES SURG, 2016, 26, p. 2268. https://doi.org/10.1007/s11695-016-2281-2.
5. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006 May, 23(5), pp. 469-80. Review. PubMed PMID: 16681555.
6. Carbajo M., García-Caballero M., Toledano M. et al. OBES SURG,2005,15,p.398. https://doi.org/10.1381/0960892053576677
7. Barzin M., Khalaj A., Motamedi M.A., Shapoori P., Azizi F., Hosseinpanah F. Safety and effectiveness of sleeve gastrectomy versus gastric bypass: one-year results of Tehran Obesity Treatment Study (TOTS). Gastroenterol Hepatol Bed Bench, 2016, 9(Suppl1), pp. S62–S69.
8. Kraljević M., Delko T., Köstler T. et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial. Trials, 2017, 18(1), p. 226. doi:10.1186/s13063-017-1957-9.
9. Rubino F., Schauer P.R., Kaplan L.M., Cummings D.E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med, 2010, 61, pp. 393-411. doi: 10.1146/annurev.med.051308.105148. Review. PubMed PMID: 20059345.
10. Adam S., Liu Y., Siahmansur T., Ho J.H., Dhage S.S., Yadav R., New J.P., Donn R., Ammori B.J., Syed A.A., Malik R.A., Soran H., Durrington P.N. Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6. Diab Vasc Dis Res, 2019 Mar, 16(2), pp. 144-152. doi: 10.1177/1479164119826479. PubMed PMID: 31014098.
11. Brethauer Stacy A. et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surgery for Obesity and Related Diseases , Volume 11 , Issue 3 , pp. 489 – 506. DOI: https://doi.org/10.1016/j.soard.2015.02.003.
12. Schiavon C.A., Bersch-Ferreira A.C., Santucci E.V. et al. Effects of Bariatric Surgery in Obese Patients with Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018, 137(11), pp. 1132–1142. doi:10.1161/CIRCULATIONAHA.117.032130.
13. Harchaoui K.E., Visser M.E., Kastelein J.J., Stroes E.S., Dallinga-Thie G.M. Triglycerides and cardiovascular risk. Curr Cardiol Rev. 2009, 5(3), pp. 216–222. doi:10.2174/157340309788970315.
14. Hokanson John E., Melissa A. Austin. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. Journal of cardiovascular risk, 1996, pp. 213-219.
15. Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet, 2014 Mar, 15, 383(9921), pp. 970-83. doi: 10.1016/S0140-6736(13)61836-X. PubMed PMID: 24269108; PubMed Central PMCID: PMC3959199.
评论
供引用:
Ospanov O.B., Eleuov G.A., Bekmurzinova F.K. RESULTS OF USING STAPLELESS MINI-GASTRIC BYPASS FOR THE TREATMENT OF THE METABOLIC SYNDROME. Surgical practice (Russia). 2019;(2):5-10. (In Russ.) https://doi.org/10.17238/issn2223-2427.2019.2.5-10
浏览:
624
JATS XML
Email this article 
